Description
A CB1 receptor antagonist; selective for CB1 over CB2 receptors in HEK293 cells overexpressing the human receptors (IC50s = 0.1 and ≥10 µM, respectively); inhibits activation of the human CB1 receptor induced by (±)-CP 55,940, AEA, and 2-AG in yeast expressing human CB1 (IC50s = 45, 37 and 230 nM, respectively); reduces food intake within 2 hours and decreases body weight by 24 hours after administration in male rats at 30 mg/kg ,
Formal name: N-(4-chlorophenyl)-N’-[3-[6-(1-pyrrolidinyl)-2-pyridinyl]phenyl]-urea
Synonyms:
Molecular weight: 392.9
CAS: 877202-74-9
Purity: ≥98%
Formulation: A solid
Product Type|Biochemicals|Receptor Pharmacology|Antagonists||Research Area|Lipid Biochemistry|Endocannabinoid/Endocannabinoid-like||Research Area|Neuroscience|Behavioral Neuroscience|Food Intake||Research Area|Neuroscience|Cannabinoid Research|CB1 & CB2 Receptors